Synergistic antiproliferative activity of suramin and α2A-interferon against human colorectal adenocarcinoma cell lines: In vitro studies
- 31 December 1994
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 30 (4) , 516-520
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of Suramin on In Vitro Growth of Fresh Human TumorsJNCI: Journal of the National Cancer Institute, 1992
- Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma CellsJNCI: Journal of the National Cancer Institute, 1990
- Growth factors and oncogenes in human gastrointestinal carcinomasJournal of Cancer Research and Clinical Oncology, 1990
- Epidermal growth factor receptor expression and suramin cytotoxicity in vitroEuropean Journal of Cancer, 1990
- Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.Journal of Cell Biology, 1989
- INTERFERONSThe Lancet, 1989
- Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suraminEuropean Journal of Biochemistry, 1988
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980